Disclaimer for the US market
The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.
Here you will find information and news about the latest events. In this way, you can stay ‘a heartbeat ahead’
of developments.
Also available as RSS feed for your RSS feed reader.
You can subscribe to our newsletter here:
Retiree back to life after cardiac arrest Our drive is to save lives and give patients suffering a cardiac arrest the chance to survive neurologically intact – anywhere in the world, in- and out-of-hospital. Our system joins the rescue chain and is being applied when, despite of all efforts, the heart cannot be restarted with…
Learn more >31-year-old man survives cardiac arrest without neurological sequelae In Europe, around 500,000 people suffer a sudden cardiac arrest every year. Outside of a hospital, only about 8% of those affected survive, and a high percentage of survivors suffer from neurological sequelae after resuscitation. A high percentage of survivors suffer from neurological sequelae after resuscitation. To…
Learn more >Family man survives thanks to CARL. Sudden cardiac death can strike anyone. Only about ten percent of patients resuscitated outside a hospital survive cardiac arrest. And after resuscitation, a high percentage of survivors suffer from persistent serious neurological sequelae, particularly affecting brain function. CARL Technology has been developed to help more people survive cardiac arrest…
Learn more >37 year old woman resuscitated after long-term cardiac arrest without neurological damage. Still today, it is generally believed that within minutes of a heart attack, the brain and other organs are severely damaged. The damage is so severe that with previous therapies successful resuscitation of the patient is very unlikely after a very short time…
Learn more >Mid-forty shows no neurological impairment after prolonged circuit bridging with CARL. The goal of CARL Therapy is to save time. Because time is life – and every minute counts when it comes to identifying the cause of a cardiac arrest and providing targeted therapy. With the help of CARL, it is possible to provide patients…
Learn more >Mid-40s woman discharged after heart failure without impaired brain function thanks to personalized CARL therapy. In a situation where further attempts of resuscitation previously seemed futile, CARL can still help. Controlled whole-body reperfusion also benefited a woman who suddenly felt a stabbing pain in her chest and collapsed while gardening on a friendly summer day.…
Learn more >